Results 21 to 30 of about 45,533 (284)

Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain [PDF]

open access: yes, 1989
The level of inhibition of rat whole brain monoamine oxidase activity produced by the irreversible monoamine oxidase inhibitor phenelzine has been studied with or without concurrent cold restraint stress.
Glover, V.   +3 more
core   +1 more source

Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells [PDF]

open access: yes, 2007
Monoamine oxidases (MAOs) are mitochondrial enzymes which control the levels of neurotransmitters in the brain and dietary amines in peripheral tissues via oxidative deamination. MAO has also been implicated in cell signalling. In this study, we describe
Ufer, C   +9 more
core   +1 more source

Pathological changes in platelet histamine oxidases in atopic eczema

open access: yesMediators of Inflammation, 1993
Increased plasma histamine levels were associated with significantly lowered diamine and type B monoamine oxidase activities in platelet-rich plasma of atopic eczema (AE) patients.
Reinhold Kiehl, Gruia Ionescu
doaj   +1 more source

Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin [PDF]

open access: yes, 1988
Purified tribulin, an endogenous monoamine oxidase (MAO) inhibitor, has been identified by direct probe insertion mass spectrometry as the indole-2,3-dione, isatin.
Watkins, P.J.   +5 more
core   +1 more source

Inhibition of  monoamine oxidase by 8-benzyloxycaffeine analogues [PDF]

open access: yes, 2010
Based on recent reports that several (E)-8-styrylcaffeinyl analogues are potent reversible inhibitors of monoamine oxidase B (MAO-B), a series of 8-benzyloxycaffeinyl analogues were synthesized and evaluated as inhibitors of baboon liver MAO-B and ...
Petzer, Jacobus P.   +4 more
core   +1 more source

Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2019
Introduction: Parkinson’s disease is the second most common neurodegenerative disease. Monoamine oxidase B inhibitors are used in the treatment of this disease concomitantly with levodopa or as monotherapy.
María del Pilar Olaya   +4 more
doaj   +1 more source

Inhibition of monoamine oxidase by indole and benzofuran derivatives [PDF]

open access: yes, 2010
Monoamine oxidase (MAO) is an important drug target for the treatment of neurological disorders. A series of indole and benzofuran derivatives were synthesised and evaluated as inhibitors of the two MAO isoforms, MAO-A and MAO-B.
Petzer, Jacobus P.   +5 more
core   +1 more source

Recent progress in directed evolution of stereoselective monoamine oxidases

open access: yesBioresources and Bioprocessing, 2019
Monoamine oxidases (MAOs) use molecular dioxygen as oxidant to catalyze the oxidation of amines to imines. This type of enzyme can be employed for the synthesis of primary, secondary, and tertiary amines by an appropriate deracemization protocol ...
Jiaqi Duan   +5 more
doaj   +1 more source

Inhibitory potency of some isatin analogues on human monoamine oxidase A and B [PDF]

open access: yes, 1992
Isatin is an endogenous compound which acts as a selective inhibitor of monoamine oxidase (MAO) B. In this study a range of isatin analogues were tested for their in vitro inhibition of human MAO A and B.
Medvedev, A.E.   +5 more
core   +1 more source

Hospitalized Patients' Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist's Classroom-Based Education

open access: yesINNOVATIONS in Pharmacy, 2010
Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using ...
Richard G. Wenzel, Jon C. Schommer
doaj   +1 more source

Home - About - Disclaimer - Privacy